XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Other Comprehensive Income (Loss)
Accumulated Deficit
Temporary Equity, Beginning Balance at Dec. 31, 2020   $ 41,323        
Temporary Equity, Beginning Balance (in shares) at Dec. 31, 2020   7,766,582        
Beginning Balance at Dec. 31, 2020 $ (23,437)   $ 1 $ 7,433   $ (30,871)
Beginning Balance (in shares) at Dec. 31, 2020     9,710,830      
Issuance of Series C convertible preferred stock, net of issuance costs of $6.2 million   $ 108,827        
Issuance of Series C convertible preferred stock, net of issuance costs of $6.2 million (in shares)   6,663,940        
Issuance of common stock on exercise of options 564     564    
Issuance of common stock on exercise of stock options (in shares)     584,614      
Stock-based compensation expense 343     343    
Net loss (13,159)         (13,159)
Temporary Equity, Ending Balance at Mar. 31, 2021   $ 150,150        
Temporary Equity, Ending Balance (in shares) at Mar. 31, 2021   14,430,522        
Ending Balance at Mar. 31, 2021 (35,689)   $ 1 8,340   (44,030)
Ending Balance (in shares) at Mar. 31, 2021     10,295,444      
Temporary Equity, Beginning Balance at Dec. 31, 2020   $ 41,323        
Temporary Equity, Beginning Balance (in shares) at Dec. 31, 2020   7,766,582        
Beginning Balance at Dec. 31, 2020 (23,437)   $ 1 7,433   (30,871)
Beginning Balance (in shares) at Dec. 31, 2020     9,710,830      
Net loss (27,470)          
Temporary Equity, Ending Balance at Jun. 30, 2021   $ 150,150        
Temporary Equity, Ending Balance (in shares) at Jun. 30, 2021   14,430,522        
Ending Balance at Jun. 30, 2021 (47,691)   $ 1 10,649   (58,341)
Ending Balance (in shares) at Jun. 30, 2021     11,333,423      
Temporary Equity, Beginning Balance at Mar. 31, 2021   $ 150,150        
Temporary Equity, Beginning Balance (in shares) at Mar. 31, 2021   14,430,522        
Beginning Balance at Mar. 31, 2021 (35,689)   $ 1 8,340   (44,030)
Beginning Balance (in shares) at Mar. 31, 2021     10,295,444      
Issuance of common stock on exercise of options 566     566    
Issuance of common stock on exercise of stock options (in shares)     1,037,979      
Stock-based compensation expense 593     593    
Net loss (14,311)         (14,311)
Repayment of promissory note 1,150     1,150    
Temporary Equity, Ending Balance at Jun. 30, 2021   $ 150,150        
Temporary Equity, Ending Balance (in shares) at Jun. 30, 2021   14,430,522        
Ending Balance at Jun. 30, 2021 (47,691)   $ 1 10,649   (58,341)
Ending Balance (in shares) at Jun. 30, 2021     11,333,423      
Beginning Balance at Dec. 31, 2021 387,825   $ 6 485,748 $ (135) (97,794)
Beginning Balance (in shares) at Dec. 31, 2021     60,263,158      
Issuance of common stock on exercise of options 629     629    
Issuance of common stock on exercise of stock options (in shares)     389,855      
Stock-based compensation expense 3,024     3,024    
Issuance of common stock under employee stock plans (in shares)     36,596      
Issuance of common stock under employee stock plans 361     361    
Net loss (19,088)         (19,088)
Other comprehensive loss (954)       (954)  
Ending Balance at Mar. 31, 2022 371,797   $ 6 489,762 (1,089) (116,882)
Ending Balance (in shares) at Mar. 31, 2022     60,689,609      
Beginning Balance at Dec. 31, 2021 $ 387,825   $ 6 485,748 (135) (97,794)
Beginning Balance (in shares) at Dec. 31, 2021     60,263,158      
Issuance of common stock on exercise of stock options (in shares) 538,616          
Net loss $ (45,785)          
Ending Balance at Jun. 30, 2022 347,889   $ 6 493,043 (1,581) (143,579)
Ending Balance (in shares) at Jun. 30, 2022     60,838,370      
Beginning Balance at Mar. 31, 2022 371,797   $ 6 489,762 (1,089) (116,882)
Beginning Balance (in shares) at Mar. 31, 2022     60,689,609      
Issuance of common stock on exercise of options 363     363    
Issuance of common stock on exercise of stock options (in shares)     148,761      
Stock-based compensation expense 2,918     2,918    
Net loss (26,697)         (26,697)
Other comprehensive loss (492)       (492)  
Ending Balance at Jun. 30, 2022 $ 347,889   $ 6 $ 493,043 $ (1,581) $ (143,579)
Ending Balance (in shares) at Jun. 30, 2022     60,838,370